An exploration of how physical activity boosts beta-cell health and eases insulin workload ...

Diabetes and insulin resistance are often spoken about in the context of heart disease, obesity, or lifestyle disorders. But what many people don’t realise is that these metabolic conditions also have ...

When it comes to keeping diabetes in check, it is not about intense workout sessions, but sustained low-intensity effort, shares Dr Manickam.

People on GLP-1 drugs like Ozempic aren't being told to exercise — they're spontaneously wanting to. Scientists believe the drugs are recalibrating the brain's motivational circuitry, and the ...

HOUSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc.

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one ...

This Note proposes reconceptualizing patents for essential medicines as a government-granted franchise right, in line with their historical status.

The FDA has granted breakthrough device designation for an implantable insulin pump designed for people with type 1 diabetes, according to an industry press release. The implantable device (Portal ...

AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of its lead product, Ampligen® (rintatolimod), for the treatment of late-stage pancreatic ...

Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these medications and your GLP-1 dose, she added. Also, seek ongoing guidance on diet and ...